PF-AtlasКлинические испытания › NCT05883293

Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis

Cell Free Fat Extract · Ранняя фаза 1

ID реестра
NCT05883293
Фаза
Ранняя фаза 1
Статус
Активно, набор закрыт
Препарат / вмешательство
Cell Free Fat Extract(CEFFE)
Спонсор
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Начало
2023-08-14
Набор участников
7
Центры
1

Об исследовании

The purpose of this clinical trial is to investigate the efficacy and safety of allogeneic adiphatic cyclic active protein in the treatment of pulmonary fibrosis. The main questions it aims to answer are: 1. Efficacy of allogeneic adiposeactive protein in the treatment of pulmonary fibrosis 2. Safety of allogeneic fat respiration active protein in the treatment of pulmonary fibrosis. A total of 7 participants will be enrolled. Participants will be asked that they will receive 2ml of each nebulized inhalation Cell Free Fat Extract (CEFFE), inhaled every 3 days, for a total of 7 nebulized inhalation treatments. The clinical trial was designed using a single-center, self-controlled trial with no control group and no blinding.

Открыть NCT05883293 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT05883293 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.